{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T09:58:42Z","timestamp":1792403922929,"version":"4.4.0"},"reference-count":25,"publisher":"Georg Thieme Verlag KG","issue":"02","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Klin Monbl Augenheilkd"],"published-print":{"date-parts":[[2025,2]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>\n          Purpose To analyze the treatment-related complications after ruthenium-106 brachytherapy in patients with uveal melanoma in terms of radiation-induced optic neuropathy, maculopathy and retinopathy, radiation-related vitreous hemorrhage, and retinal detachment, as well as secondary glaucoma and radiogenic cataract. In addition, the course of visual acuity was analyzed.<\/jats:p><jats:p>\n          Patients\/Methods and Materials This retrospective study included 608 patients treated with ruthenium-106 brachytherapy between January 2008 and December 2010 at the Department of Ophthalmology, University Hospital Essen. The follow-up time was 11 years. The occurrence of the radiation-induced complications was analyzed using the Kaplan-Meier method. Cox regression was used for univariate and multivariate risk factor analyses. Hazard ratios were calculated for each variable.<\/jats:p><jats:p>\n          Results Regarding the complications, 34% (N\u2009=\u2009207) of the patients had no reported side effects or complications during follow-up. Radiation optic neuropathy was observed in 18.8% (N\u2009=\u2009114) of the patients, with a median time to onset of 16 months (range: 3\u200a\u2013\u200a78 months). Radiation maculopathy occurred in 8.2% (N\u2009=\u200950) after a median time of 17 months (range: 3\u200a\u2013\u200a67 months). Radiation retinopathy was observed in 20.1% (N\u2009=\u2009122), with a median time to onset of 21 months (range: 6\u200a\u2013\u200a67 months). Secondary glaucoma developed in 9.7% of the patients (N\u2009=\u200953) and radiogenic cataract in 46.8% (N\u2009=\u2009227). Vitreous hemorrhage (11.8%, N\u2009=\u200972) and scleral necrosis (2.1%, N\u2009=\u200913) occurred relatively rarely.<\/jats:p><jats:p>\n          Conclusion The observed radiogenic complication rate is comparable with that reported in previous studies.<\/jats:p>","DOI":"10.1055\/a-2275-5575","type":"journal-article","created":{"date-parts":[[2024,2,24]],"date-time":"2024-02-24T00:09:45Z","timestamp":1708733385000},"page":"116-126","source":"Crossref","is-referenced-by-count":5,"title":["Treatment-Related Complications and Functional Results after Ruthenium-106 Brachytherapy in Small to Medium Size Uveal Melanomas (Part 2)"],"prefix":"10.1055","volume":"242","author":[{"given":"Fotios","family":"Lalos","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, University Hospital of Essen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Fl\u00fchs","sequence":"additional","affiliation":[{"name":"Department of Radiotherapy, University Hospital of Essen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maja","family":"Guberina","sequence":"additional","affiliation":[{"name":"Department of Radiotherapy, University Hospital of Essen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norbert","family":"Bornfeld","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, University Hospital of Essen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Stuschke","sequence":"additional","affiliation":[{"name":"Department of Radiotherapy, University Hospital of Essen, Germany"},{"name":"German Cancer Consortium (DKTK), Heidelberg, Partner Site University Hospital Essen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Sauerwein","sequence":"additional","affiliation":[{"name":"Department of Radiotherapy, University Hospital of Essen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaos E.","family":"Bechrakis","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, University Hospital of Essen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2024,4,4]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/eye.2016.275","article-title":"Uveal melanoma: relatively rare but deadly cancer","volume":"31","author":"S Kaliki","year":"2017","journal-title":"Eye (Lond)"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1016\/j.ophtha.2011.01.040","article-title":"Uveal melanoma: trends in incidence, treatment, and survival","volume":"118","author":"A D Singh","year":"2011","journal-title":"Ophthalmology"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1016\/j.ophtha.2007.01.032","article-title":"Incidence of uveal melanoma in Europe","volume":"114","author":"G Virgili","year":"2007","journal-title":"Ophthalmology"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1136\/bjo.70.11.844","article-title":"Results after beta-irradiation (106Ru\/106Rh) of choroidal melanomas: 20 years\u02bc experience","volume":"70","author":"P K Lommatzsch","year":"1986","journal-title":"Br J Ophthalmol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1136\/bjo.50.3.147","article-title":"Radiotherapy for malignant melanoma of the choroid","volume":"50","author":"H B Stallard","year":"1966","journal-title":"Br J Ophthalmol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brachy.2013.11.008","article-title":"The American Brachytherapy Society consensus guidelines for plaque brachytherapy of uveal melanoma and retinoblastoma","volume":"13","author":"American Brachytherapy Society \u2013 Ophthalmic Oncology Task Force. Electronic address: paulfinger@eyecancer.com","year":"2014","journal-title":"Brachytherapy"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1159\/000425685","article-title":"Dosimetry and design of radioactive eye plaques","volume":"30","author":"D Fl\u00fchs","year":"1997","journal-title":"Front Radiat Ther Oncol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/eye.2012.241","article-title":"Radiotherapy for ocular tumours","volume":"27","author":"C Stannard","year":"2013","journal-title":"Eye (Lond)"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1159\/000479558","article-title":"Dose distributions and treatment margins in ocular brachytherapy with 106Ru eye plaques","volume":"4","author":"E St\u00f6ckel","year":"2018","journal-title":"Ocul Oncol Pathol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1159\/000456717","article-title":"Monte Carlo estimation of absorbed dose distributions obtained from heterogeneous 106Ru eye plaques","volume":"3","author":"F J Zaragoza","year":"2017","journal-title":"Ocul Oncol Pathol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1007\/BF00195358","article-title":"Radiation effects on the optic nerve observed after brachytherapy of choroidal melanomas with 106Ru\/106Rh plaques","volume":"232","author":"P K Lommatzsch","year":"1994","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1016\/j.ophtha.2004.03.027","article-title":"Ocular complications after iodine brachytherapy for large uveal melanomas","volume":"111","author":"I Puusaari","year":"2004","journal-title":"Ophthalmology"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/S0161-6420(89)32806-5","article-title":"Reasons for enucleation after plaque radiotherapy for posterior uveal melanoma. Clinical findings","volume":"96","author":"C L Shields","year":"1989","journal-title":"Ophthalmology"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1136\/bjo.80.8.732","article-title":"Radiation related complications after ruthenium plaque radiotherapy of uveal melanoma","volume":"80","author":"P Summanen","year":"1996","journal-title":"Br J Ophthalmol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/j.ophtha.2006.10.039","article-title":"Incidence of cataract and outcomes after cataract surgery in the first 5 years after iodine 125 brachytherapy in the Collaborative Ocular Melanoma Study: COMS Report No.\u200927","volume":"114","author":"Collaborative Ocular Melanoma Study Group","year":"2007","journal-title":"Ophthalmology"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0161-6420(86)33770-9","article-title":"Neovascular glaucoma after helium ion irradiation for uveal melanoma","volume":"93","author":"M K Kim","year":"1986","journal-title":"Ophthalmology"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1038\/eye.2009.43","article-title":"Ocular complications following I-125 brachytherapy for choroidal melanoma","volume":"23","author":"J C Wen","year":"2009","journal-title":"Eye (Lond)"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1136\/bjophthalmol-2013-303331","article-title":"Pars plana vitrectomy to repair retinal detachment following brachytherapy for uveal melanoma","volume":"97","author":"G Beykin","year":"2013","journal-title":"Br J Ophthalmol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1097\/IAE.0b013e3182340cc1","article-title":"Vitreous hemorrhage after plaque radiotherapy for uveal melanoma","volume":"32","author":"C Bianciotto","year":"2012","journal-title":"Retina"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/eye.2015.20","article-title":"Incidence and indications for pars plana vitrectomy following the treatment of posterior uveal melanomas in Scotland","volume":"29","author":"S N Chia","year":"2015","journal-title":"Eye (Lond)"},{"key":"ref21","first-page":"2085","article-title":"Exudative retinal detachment from malignant uveal melanoma: predictors and prognostic significance","volume":"42","author":"T Kivel\u00e4","year":"2001","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/ceo.13928","article-title":"Scleral necrosis after brachytherapy for uveal melanoma: Analysis of risk factors","volume":"49","author":"L Jabbarli","year":"2021","journal-title":"Clin Exp Ophthalmol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/j.ophtha.2012.10.021","article-title":"Scleral necrosis after plaque radiotherapy of uveal melanoma: a case-control study","volume":"120","author":"S Kaliki","year":"2013","journal-title":"Ophthalmology"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.ijrobp.2005.02.059","article-title":"Visual acuity after Ruthenium(106) brachytherapy of choroidal melanomas","volume":"63","author":"B Damato","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1136\/bjo.2009.157701","article-title":"Ruthenium-106 plaque brachytherapy for thick posterior uveal melanomas","volume":"93","author":"N Kaiserman","year":"2009","journal-title":"Br J Ophthalmol"}],"container-title":["Klinische Monatsbl\u00e4tter f\u00fcr Augenheilkunde"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-2275-5575.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T00:28:23Z","timestamp":1739492903000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-2275-5575"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,23]]},"references-count":25,"journal-issue":{"issue":"02","published-online":{"date-parts":[[2025,2,13]]},"published-print":{"date-parts":[[2025,2]]}},"URL":"https:\/\/doi.org\/10.1055\/a-2275-5575","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0023-2165","1439-3999"],"issn-type":[{"value":"0023-2165","type":"print"},{"value":"1439-3999","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,2,23]]},"published":{"date-parts":[[2024,2,23]]}}}